Ostrum Asset Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.35M Sell
19,519
-38,649
-66% -$4.46M 0.13% 116
2025
Q4
$6.12M Sell
58,168
-18,424
-24% -$1.73M 0.29% 46
2025
Q3
$6.43M Buy
76,592
+2,462
+3% +$203K 0.29% 54
2025
Q2
$5.87M Sell
74,130
-1,799
-2% -$143K 0.28% 61
2025
Q1
$6.82M Buy
75,929
+17,616
+30% +$1.64M 0.36% 44
2024
Q4
$5.8M Buy
58,313
+9,601
+20% +$990K 0.5% 29
2024
Q3
$5.53M Buy
48,712
+10,072
+26% +$1.2M 0.46% 41
2024
Q2
$4.78M Sell
38,640
-31,605
-45% -$4.07M 0.42% 47
2024
Q1
$9.27M Sell
70,245
-2,611
-4% -$322K 0.73% 12
2023
Q4
$7.94M Buy
72,856
+28,629
+65% +$2.97M 0.69% 13
2023
Q3
$4.55M Sell
44,227
-5,679
-11% -$612K 0.42% 51
2023
Q2
$5.76M Sell
49,906
-566
-1% -$64.3K 0.48% 41
2023
Q1
$5.37M Buy
+50,472
New +$5.45M 0.47% 40

Other funds holding MRK

Ostrum Asset Management's MRK Position: Q1 2026 in Review

Ostrum Asset Management reduced its Merck (MRK) stake by 66% in Q1 2026, selling an estimated $4.46M and leaving 19,519 shares worth $2.35M. The position accounts for 0.13% of the portfolio, ranked #116.

Ostrum Asset Management first reported a position in MRK in Q1 2023 and has held it in 13 quarters since. The position peaked at $9.27M in Q1 2024. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Ostrum Asset Management held 19,519 shares of Merck worth $2.35M as of Q1 2026.
  • Ostrum Asset Management sold 38,649 Merck shares in Q1 2026, an estimated $4.46M.
  • Merck made up 0.13% of Ostrum Asset Management's portfolio in Q1 2026, its #116 holding.
  • Ostrum Asset Management first reported a position in Merck in Q1 2023 and has held it in 13 quarters since.
  • Ostrum Asset Management's Merck position peaked at $9.27M in Q1 2024.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Ostrum Asset Management's 13F filing for Q1 2026, filed 14 May 2026.